127 related articles for article (PubMed ID: 21306764)
1. Dose-dependence of sublingual immunotherapy shown by meta-analysis.
Frati F; Incorvaia C; Scurati S; Sensi L; Marcucci F
J Allergy Clin Immunol; 2011 Apr; 127(4):1076-7; author reply 1077-8. PubMed ID: 21306764
[No Abstract] [Full Text] [Related]
2. Necessity of product-specific assessments or restrictions of meta-analyses to well-designed and well-powered studies.
Sieber J;
J Allergy Clin Immunol; 2011 Apr; 127(4):1075-6; author reply 1077-8. PubMed ID: 21306765
[No Abstract] [Full Text] [Related]
3. Is oral immunotherapy too good to be true?
Ledford DK
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):1-2. PubMed ID: 14756456
[No Abstract] [Full Text] [Related]
4. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.
Penagos M; Compalati E; Tarantini F; Baena-Cagnani R; Huerta J; Passalacqua G; Canonica GW
Ann Allergy Asthma Immunol; 2006 Aug; 97(2):141-8. PubMed ID: 16937742
[TBL] [Abstract][Full Text] [Related]
5. Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa study.
Pfaar O; Barth C; Jaschke C; Hörmann K; Klimek L
Int Arch Allergy Immunol; 2011; 154(4):336-44. PubMed ID: 20975285
[TBL] [Abstract][Full Text] [Related]
6. Multiallergen immunotherapy for allergic rhinitis and asthma.
Nelson HS
J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
[TBL] [Abstract][Full Text] [Related]
7. Local allergic rhinitis: allergen tolerance and immunologic changes after preseasonal immunotherapy with grass pollen.
Rondón C; Blanca-López N; Aranda A; Herrera R; Rodriguez-Bada JL; Canto G; Mayorga C; Torres MJ; Campo P; Blanca M
J Allergy Clin Immunol; 2011 Apr; 127(4):1069-71. PubMed ID: 21277626
[No Abstract] [Full Text] [Related]
8. An evidence based overview of sublingual immunotherapy in children.
Scala G; Di Rienzo Businco A; Ciccarelli A; Tripodi S
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):23-6. PubMed ID: 19944006
[TBL] [Abstract][Full Text] [Related]
9. SQ-standardised grass tablet sublingual immunotherapy: persistent clinical benefit and progressive immunological changes during three years treatment.
Durham SR
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():121-7; discussion 127-31. PubMed ID: 20799452
[No Abstract] [Full Text] [Related]
10. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
11. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.
Kleine-Tebbe J; Ribel M; Herold DA
Allergy; 2006 Feb; 61(2):181-4. PubMed ID: 16409193
[TBL] [Abstract][Full Text] [Related]
12. [Grazax--treatment for grass pollen hay fever].
Svendsen UG
Ugeskr Laeger; 2008 Jan; 170(3):135-7. PubMed ID: 18208728
[TBL] [Abstract][Full Text] [Related]
13. Monoid sublingual immunotherapy.
Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
Smith H; White P; Annila I; Poole J; Andre C; Frew A
J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
[TBL] [Abstract][Full Text] [Related]
15. Sublingual immunotherapy.
Corrigan C
J Allergy Clin Immunol; 2007 Feb; 119(2):515; author reply 515-7. PubMed ID: 17187850
[No Abstract] [Full Text] [Related]
16. Future developments in sublingual immunotherapy.
Didier A
Allergy; 2006; 61 Suppl 81():29-31. PubMed ID: 16792604
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults.
Nelson HS; Nolte H; Creticos P; Maloney J; Wu J; Bernstein DI
J Allergy Clin Immunol; 2011 Jan; 127(1):72-80, 80.e1-2. PubMed ID: 21211643
[TBL] [Abstract][Full Text] [Related]
18. Update on sublingual immunotherapy treatment regimes.
Spangfort MD
Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):244. PubMed ID: 17124783
[No Abstract] [Full Text] [Related]
19. [Instead of hyposensitization by injection. Dissolving immunotherapy under the tongue?].
Klein F
MMW Fortschr Med; 2007 Jan; 149(3):16. PubMed ID: 17632861
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents.
Blaiss M; Maloney J; Nolte H; Gawchik S; Yao R; Skoner DP
J Allergy Clin Immunol; 2011 Jan; 127(1):64-71, 71.e1-4. PubMed ID: 21211642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
